Key facts
- It has raised $28.5M; the latest was Early Stage VC ($14.5M) in Mar 2026.
- Notable investors include Legend Capital, Dalton Venture, Proxima Ventures (China), Guangzhou Yuexiu Industrial Investment Fund Management, Daoyuan Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Rhino Health (Surgical Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Rhino Health (Surgical Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rhino Health (Surgical Devices)
Developer and manufacturer of high-end medical equipment designed for ophthalmic surgery. The company's equipment include cataract phacoemulsification instrument, vitrectomy surgical system, ultrasonic vitrectomy, laser vitrectomy system and endoscopic OCT, enabling surgeons to have a one-stop training service for ophthalmic surgeries.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- xiranhealth.net/
- Ownership
- Privately Held (backing)
Rhino Health (Surgical Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rhino Health (Surgical Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rhino Health (Surgical Devices) in its N-PORT filings yet. We sweep new filings monthly.